Seminars in Respiratory and Critical Care Medicine

Article	Citations
Prevention and Management of Delirium in the Intensive Care Unit	51
Cutaneous Sarcoidosis	41
Adenovirus: Epidemiology, Global Spread of Novel Types, and Approach to Treatment	34
Staphylococcus aureus Pneumonia in the Community	33
Ocular Sarcoidosis	31
Vasopressor Therapy in the Intensive Care Unit	27
Lymphangioleiomyomatosis	25
Artificial Intelligence in the Intensive Care Unit	24
Q Fever (Coxiella Burnetii)	23
Determinants and Management of the Post–Pulmonary Embolism Syndrome	23
FeNO in Asthma	23
Hermansky–Pudlak Syndrome	22
New Antibiotics for Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia	22
Cardiac Sarcoidosis	21
What Is the Utility of Measuring Lactate Levels in Patients with Sepsis and Septic Shock?	20
Management and Challenges of Severe Traumatic Brain Injury	20
Advanced Pulmonary Sarcoidosis	19
Mesenchymal Stem/Stromal Cells Therapy for Sepsis and Acute Respiratory Distress Syndrome	19
Physiological and Pathophysiological Consequences of Mechanical Ventilation	19
Nocardia spp.: A Rare Cause of Pneumonia Globally	19
Monitoring Lung Injury Severity and Ventilation Intensity during Mechanical Ventilation	17
Pathophysiology of Bronchiectasis	17
COVID-19 and Its Implications for Thrombosis and Anticoagulation	16
Obesity and Asthma	15
Primary Ciliary Dyskinesia	14

The Lung Allocation Score and Its Relevance	14
Pulmonary Langerhans Cell Histiocytosis	13
Health-Related Quality of Life in Sarcoidosis	12
Middle East Respiratory Syndrome Coronavirus and Severe Acute Respiratory Syndrome Coronavirus	12
Pulmonary Alveolar Proteinosis Syndrome	12
Sarcoidosis-Associated Pulmonary Hypertension	12
Elderly Patients in the Intensive Care Unit	12
Lung Cancer Screening	11
Microbial Epidemiology of the Cystic Fibrosis Airways: Past, Present, and Future	11
Physical Therapy and Rehabilitation in Chronic Obstructive Pulmonary Disease Patients Admitted to the Intensive Care Unit	11
Hepatic Sarcoidosis: Current Concepts and Treatments	11
Targeted Therapy for Non-Small Cell Lung Cancer	10
New Developments in the Pathogenesis of Pulmonary Cysts in Birt–Hogg–Dubé Syndrome	10
Severe Infections Due to Respiratory Viruses	10
The Impact of Resistant Bacterial Pathogens including Pseudomonas aeruginosa and Burkholderia on Lung Transplant Outcomes	9
Clinical Decision-Making in Hypersensitivity Pneumonitis: Diagnosis and Management	9
Pneumonic versus Nonpneumonic Exacerbations of Chronic Obstructive Pulmonary Disease	9
The Role of Streptococcus pneumoniae in Community-Acquired Pneumonia	9
Update on Sepsis Epidemiology in the Era of COVID-19	9
Small Cell Lung Cancer: Advances in Diagnosis and Management	9
Familial Interstitial Lung Disease	9
Combined Pulmonary Fibrosis and Emphysema	9
Antimicrobial Stewardship in the ICU	9
Amyloid in the Lung	9
Endemic Fungi Presenting as Community-Acquired Pneumonia: A Review	8
Risk Stratification in Acute Pulmonary Embolism: The Latest Algorithms	8
Middle East Respiratory Syndrome Coronavirus	8
Radiographic and Histopathologic Features in Sarcoidosis: A Pictorial Display	8
Life-Threatening Hemoptysis	8
Invasive Pulmonary Aspergillosis in Hospital and Ventilator-Associated Pneumonias	8
Fungal Infection in Lung Transplantation	8
Integrated Multiorgan Bedside Ultrasound for the Diagnosis and Management of Sepsis and Septic Shock	8
Methicillin-Resistant Staphylococcus aureus Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia	8
Melioidosis: A Neglected Cause of Community-Acquired Pneumonia	8
Screening Sarcoidosis Patients for Occult Disease	8
The Great Masquerader: Tuberculosis Presenting as Community-Acquired Pneumonia	8
The State of the Science in Patient-Reported Outcomes for Patients with Lung Cancer	8
Balancing Altered Calcium Metabolism with Bone Health in Sarcoidosis	8
Acute Rejection in the Modern Lung Transplant Era	7
Nonspecific Interstitial Pneumonia	7
COVID-19 in Immunocompromised Patients: A Systematic Review	7
Pseudomonas aeruginosa in Bronchiectasis	7
Thoracic Involvement in IgG4-Related Disease	7
Antiviral Treatments for Influenza	7
Prevention of Venous Thromboembolism in Acutely Ill Medical Patients: A New Era	7
Mechanical Ventilation for COVID-19 Patients	7
The Burden of Neurosarcoidosis: Essential Approaches to Early Diagnosis and Treatment	7
Any Role of High-Dose Vitamin C for Septic Shock in 2021?	7
Which Biomarkers Can Be Used as Diagnostic Tools for Infection in Suspected Sepsis?	7
Pseudomonas aeruginosa Pneumonia: Evolution of Antimicrobial Resistance and Implications for Therapy	7

Mycobacteria: Selection of Transplant Candidates and Post–lung Transplant Outcomes	6
Viral Ventilator-Associated Pneumonia/Hospital-Acquired Pneumonia	6
Aspergillus-Associated Endophenotypes in Bronchiectasis	6
Invasive Pulmonary Aspergillosis in Chronic Obstructive Pulmonary Disease Exacerbations	6
Fulminant Clostridioides difficile Infection: A Review of Treatment Options for a Life-Threatening Infection	6
Community-Acquired Pneumonia: A Global Perspective	6
Emerging Resistance of Gram Negative Pathogens in Community-Acquired Pneumonia	6
Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia and Ventilator-Associated Tracheobronchitis in COVID-19	6
VATS and Minimally Invasive Resection in Early-Stage NSCLC	6
Bronchiolitis and Bronchiolar Disorders	6
Pulmonary Alveolar Microlithiasis	6
Chronic Lung Allograft Dysfunction: Evolving Concepts and Therapies	5
Glucocorticoid Therapy in COVID-19	5
Chronic Obstructive Pulmonary Disease in the Intensive Care Unit: Antibiotic Treatment of Severe Chronic Obstructive Pulmonary Disease Exacerbations	5
COVID-19 Vaccines—All You Want to Know	5
Bronchiectasis Exacerbations: Definitions, Causes, and Acute Management	5
Clinical and Radiological Phenotypes and Endotypes	5
Extracorporeal Membrane Oxygenation as a Bridge to Lung Transplant	5
Pulmonary Embolism in Pregnancy	5
Optimizing Fluid Resuscitation and Preventing Fluid Overload in Patients with Septic Shock	5
“Long Haulers”	5
Respiratory Syncytial Virus	5
Primary Graft Dysfunction	5
Nontuberculous Mycobacteria	5
Antibody-Mediated Rejection and Lung Transplantation	5
Lung Volume Reduction in Pulmonary Emphysema	5
End-of-Life Issues in Intensive Care Units	5
Antibiotic Optimization in the Intensive Care Unit	4
Bronchoscopic Lung Volume Reduction for Emphysema: Review and Update	4
Imaging of Lung Cancer Staging	4
Infections Due to Acinetobacter baumannii–calcoaceticus Complex: Escalation of Antimicrobial Resistance and Evolving Treatment Options	4
Artificial Intelligence in Lung Imaging	4
Comorbidities and Readmissions in Survivors of Acute Hypercapnic Respiratory Failure	4
Diagnosis and Initial Investigation of Bronchiectasis	4
Immunotherapy in Advanced Non-Small Cell Lung Cancer	4
Update on Lung Cancer Screening	4
Viral Respiratory Infections: New Tools for a Rapid Diagnosis	4
The Immune Response to Respiratory Viruses: From Start to Memory	4
Nebulized Antibiotics for Healthcare- and Ventilator-Associated Pneumonia	4
Suspected Acute Pulmonary Embolism: Gestalt, Scoring Systems, and Artificial Intelligence	3
Community-Acquired Respiratory Viruses Post–Lung Transplant	3
Severe Skin and Soft-Tissue Infections	3
COVID-19 in Children: Update on Diagnosis and Management	3
Nutrition in Asthma	3
Surgery as a Component of Multimodality Care for Known Stage IIIA-N2 Non-small Cell Lung Cancer	3
Insights Regarding the Berlin Definition of ARDS from Prospective Observational Studies	3
Overlap Syndromes in Sarcoidosis: Clinical Features and Outcomes	3
How Antibiotics Stewardship Can Be Safely Implemented in Patients with Septic Shock?	3
Work-Related Sleep Disorders: Causes and Impacts	3
Molecular Diagnostics in Non-Small Cell Lung Carcinoma	3
Nonlife-Threatening Sarcoidosis	3
Classical and Molecular Techniques to Diagnose HAP/VAP	3
Nonantibiotic Pharmacological Treatment of Severe Chronic Obstructive Pulmonary Disease Exacerbations	3
The Origins of Severe Acute Respiratory Syndrome-Coronavirus-2	3
Advanced Cystic Fibrosis Lung Disease and Lung Transplantation in the Era of Cystic Fibrosis Transmembrane Conductance Regulator Modulators	3
Imaging in the Intensive Care Unit	3
Use of Antiviral Agents and other Therapies for COVID-19	3
The Emerging Spectrum of Respiratory Diseases in the U.S. Cannabis Industry	3
Diagnosis and Management of Cystic Fibrosis Exacerbations	3
The Pulmonary Embolism Response Team: Why and How?	3
HAP and VAP after Guidelines	3
Direct Oral Anticoagulants in the Treatment of Venous Thromboembolism: Use in Patients with Advanced Renal Impairment, Obesity, or Other Weight-Related Special Populations	3
Influenza Virus in Community-Acquired Pneumonia: Current Understanding and Knowledge Gaps	3
Breathlessness with Pleural Effusion: What Do We Know?	3
Environmental Interventions for Asthma	3
Should Vasopressors Be Started Early in Septic Shock?	3
Asymmetrical Lung Injury: Management and Outcome	3
Transmission and Risk Factors of COVID-19 among Health Care Workers	3
Local Ablative Therapies in Oligometastatic NSCLC: New Data and New Directions	3
Intra-abdominal Infections	3
Sepsis and Septic Shock: Evolving Evidence, Evolving Paradigms	3
Beyond the Lungs—Emerging Challenges in Adult Cystic Fibrosis Care	3
Aggressive Therapy for Acute Pulmonary Embolism: Systemic Thrombolysis and Catheter-Directed Approaches	3
Indwelling Pleural Catheter: Management of Complications	2
Hantavirus	2
Malignant Pleural Effusions in the Era of Immunotherapy and Antiangiogenic Therapy	2
Evaluation and Management of Indeterminate Pulmonary Nodules on Chest Computed Tomography in Asymptomatic Subjects: The Principles of Nodule Guidelines	2
Venous Thromboembolism: Genetics and Thrombophilias	2
Nonmalignant Pleural Effusions	2
Clinical Relevance of Fungi in Cystic Fibrosis	2

Modeling Mechanical Ventilation In Silico—Potential and Pitfalls	2
Pathology and Mineralogy of the Pneumoconioses	2
Airway Clearance and Mucoactive Therapies	2
Immunotherapy and Radiation Therapy for Non-Small Cell Lung Cancer—A Stimulating Partnership	2
New Insights into the Prevention of Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia Caused by Viruses	2
Microbiology Assessments in Critically Ill Patients	2
Exercise and Airway Clearance Techniques in Cystic Fibrosis	2
Evidence for the Application of Sepsis Bundles in 2021	2
CFTR Modulators: Current Status and Evolving Knowledge	2
Cardiovascular Complications in Coronavirus Disease 2019—Pathogenesis and Management	2
An Update on Cardiorespiratory Physiotherapy during Mechanical Ventilation	2
Common Variable Immunodeficiency and Other Immunodeficiency Syndromes in Bronchiectasis	2
HIV and COVID-19 Disease	2
Metabolic and Endocrine Challenges	2
The Pulmonary Vasculature	2
Other Respiratory Viruses as a Cause of Community-Acquired Pneumonia	2
Prone Positioning and Neuromuscular Blocking Agents as Adjunctive Therapies in Mechanically Ventilated Patients with Acute Respiratory Distress Syndrome	2
Diagnosing Cystic Fibrosis in Adults	2
Lung Cancer: Advances in Diagnosis and Management	2
Respiratory Viruses and Cystic Fibrosis	2
Artificial Intelligence in Quantitative Chest Imaging Analysis for Occupational Lung Disease	2
Expert Review on Nonsurgical Management of Parapneumonic Effusion: Advances, Controversies, and New Directions	2
Management of Severe Influenza	2
Control of Breathing	2
Noninvasive Ventilation and High-Flow Nasal Therapy Administration in Chronic Obstructive Pulmonary Disease Exacerbations	2
Optimal Sedation and Pain Management: A Patient- and Symptom-Oriented Paradigm	2
Nontuberculous Mycobacteria in Cystic Fibrosis in the Era of Cystic Fibrosis Transmembrane Regulator Modulators	2
Mechanical Ventilation during ECMO: Lessons from Clinical Trials and Future Prospects	2
Liberation from Mechanical Ventilation: Established and New Insights	2
Severity of Illness Scores and Biomarkers for Prognosis of Patients with Coronavirus Disease 2019	2
What Is the Role of Steroids for Septic Shock in 2021?	2
High-Risk Pulmonary Embolism: Embolectomy and Extracorporeal Membrane Oxygenation	2
Automated Blood Pressure Control	2
Survival Outcome of Sepsis in Recipients of Solid Organ Transplant	2
Global Trends in Occupational Lung Disease	2
Blood Gas Transport: Carriage of Oxygen and Carbon Dioxide in Blood	2
Transbronchial Lung Cryobiopsy for Diffuse Parenchymal Lung Disease	2
Malignant Central Airway Obstruction: What's New?	2
New Markers for Management of Mesothelioma	2